The global Intrauterine Devices Market was valued at US$ 3.0 billion in 2022 and it is anticipated to grow up to US$ 4.4 billion by 2032, at a CAGR of 3.9% during the forecast period.
Download Free Sample of Report- https://www.globalinsightservices.com/request-sample/GIS24311 ?utm_source=%2F%3Futm_source%3Dpranalipawar%26utm_medium%3Dlinkewire%26utm_campaign%3D29112023
An Intrauterine device is a T-shaped plastic or copper birth control medical device inserted into the uterus to prevent pregnancy. It releases copper into the womb, altering the cervical mucus and making it difficult for sperm to reach and survive an egg. It can also prevent a fertilized egg from implanting itself. IUDs are widely preferred over other methods of contraception because they are compact, safe, and cost-effective, and they have no hormonal side effects such as acne, headaches, or breast tenderness. It is currently available in various types that can last for a period of 5 to 10 years.
Market Drivers and Trends
The rise in awareness over the availability of the devices through campaigns is the primary driver of the industry’s growth. One of the key factors influencing global demand for IUDs are initiatives taken by various countries’ health agencies, in collaboration with non-profit organizations (NPOs), to raise awareness about family planning, the benefits of birth control measures, and health-related issues caused by unplanned pregnancies are promoting market growth. Furthermore, because IUDs have a very low risk of ectopic pregnancy, they are gaining popularity among nulliparous women and adolescents who have never given birth and are at a higher risk for negative birth outcomes such as breast and reproductive cancers.
Furthermore, the rise in unplanned and unwanted pregnancies, which has become one of the world’s major concerns. For Instance, according to the World Health Organization (WHO) and the International Federation of Medical Students’ Associations’ 2018 report, approximately 22 million unsafe abortions are performed globally each year, resulting in the deaths of an estimated 47,000 women, Aside from that, the development of advanced product variants with fewer side effects, such as postpartum, slimmer, and reusable IUDs, is expected to offer lucrative growth opportunities to industry investors in the coming years. These factors are expected to drive the growth of the global Intrauterine Devices Market.
Market Restraints and Challenges
The factors that are impeding the market lack of proper knowledge on use of devices, pelvic inflammatory infection, infertility issues, and limited access for conception are limiting the market growth. Additionally, fewer patients experience side effects such as cramps, irregular periods, heavy periods with stronger cramping and others are hindering the global Intrauterine Devices Market growth and further restrict the growth of the market.
Major Players in the Global Intrauterine Devices Market
The key players studied in the global Intrauterine Devices Market are Abviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the market, because the intrauterine devices market is heavily reliant on physician-administered and physician-prescribed intrauterine devices, the number of patient visits for contraception in hospitals has decreased. However, restrictions on physician office visits without an emergency were imposed during the first few months of the ongoing pandemic. Half of the population considering family planning during COVID-19 shifted their interest from intrauterine devices to other contraception methods such as contraception pills, resulting in a worldwide decline in demand for intrauterine device products. The Health Management Information System, which is part of the Health Ministry’s 2020 union, reported that the rate of intrauterine device insertion decreased by 21% during the COVID-19.
According to a research study by Anita Makins, which was published in Gynecology & Obstetrics Journal May 2020, states that there is an huge stock-out of contraceptive methods during the COVID-19 pandemic 2020. Furthermore, the United Nations Population Fund predicted that 46 countries that typically receive supplies from them has experienced stock-outs of one or more modern methods, which includes copper intrauterine devices, implants, oral contraceptive pills, and condoms, over the next six months beginning in May 2020.
Get a customized scope to match your need, ask an expert –https://www.globalinsightservices.com/request-customization/GIS24311?utm_source=%2F%3Futm_source%3Dpranalipawar%26utm_medium%3Dlinkewire%26utm_campaign%3D29112023
Global Intrauterine Devices Market Segmentation
By Type
- Copper
- Hormonal
By Age Group
- 15-24
- 25-34
- 35-44
- Above 44
By End-User
- Hospitals
- Clinics
- Community Healthcare Centers
- Others
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/